Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
Annika HerlemannHuei-Chung HuangRidwan AlamJeffery J TosoianHyung L KimEric E KleinJeffry P SimkoJune M ChanBrian R LaneJohn W DavisElai DavicioniFelix Y FengPeter McCueHyun KimRobert B DenTarek A BismarPeter R CarrollMatthew R CooperbergPublished in: Prostate cancer and prostatic diseases (2019)
NCCN risk groups, including F-IR, are highly heterogeneous and should be replaced with multivariable risk-stratification. In particular, incorporating Decipher may be useful for safely expanding the use of AS in this patient population.
Keyphrases